Dashboard
Manage Tickers

ACET Adicet Bio, Inc.

Nasdaq adicetbio.com


$ 0.99 $ -0.05 (-4.81 %)    

Friday, 17-Oct-2025 19:52:11 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 0.99
$ 1.06
$ 0.94 x 500
$ 1.03 x 9
$ 0.94 - $ 1.06
$ 0.45 - $ 1.54
1,911,550
na
82.42M
$ 1.68
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 03-06-2025 01-01-1970 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-19-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-15-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-15-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-12-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 03-12-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 03-18-2019 12-31-2018 10-K
28 11-13-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-29-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

adicet-bio-doses-first-patient-in-phase-1-trial-of-adi-001-for-treatment-refractory-rheumatoid-arthritis
Adicet Bio Doses First Patient In Phase 1 ...
10/16/2025 11:06:22

guggenheim-maintains-buy-on-adicet-bio-raises-price-target-to-8
Guggenheim Maintains Buy on Adicet Bio, Ra...
10/08/2025 12:29:18

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $7 to $8.

adicet-bios-lupus-trial-delivers-100-response-setting-stage-for-phase-2
Adicet Bio's Lupus Trial Delivers 100% Res...
10/07/2025 15:05:59

Adicet Bio reported strong Phase 1 lupus trial results with ADI-001, showing 100% response in nephritis patients and raising $8...

adicet-bio-priced-registered-direct-offering-of-70m-shares-at-1share-and-pre-funded-warrants-to-purchase-10m-shares-at-09999-per-pre-funded-warrant-with-gross-proceeds-of-approximately-80m
Adicet Bio Priced Registered Direct Offeri...
10/07/2025 11:03:58

adicet-bio-shares-initial-safety-and-efficacy-data-from-the-first-seven-patients-dosed-with-adi-001-in-the-ongoing-phase-1-study-in-patients-with-autoimmune-diseases
Adicet Bio Shares Initial Safety And Effic...
10/07/2025 10:51:49

Clinical data to date supports a potentially transformational approach to treating autoimmune diseases with an off-the-shelf, o...

guggenheim-reiterates-buy-on-adicet-bio-maintains-7-price-target
Guggenheim Reiterates Buy on Adicet Bio, M...
09/19/2025 12:45:28

Guggenheim analyst Yatin Suneja reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $7 price target.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 21:06:03

adicet-bio-q2-eps-034-misses-030-estimate
Adicet Bio Q2 EPS $(0.34) Misses $(0.30) E...
08/07/2025 20:46:49

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.30) ...

adicet-bio-doses-first-systemic-sclerosis-patient-in-phase-1-clinical-trial-of-adi-001
Adicet Bio Doses First Systemic Sclerosis ...
07/24/2025 11:09:16

hc-wainwright--co-assumes-adicet-bio-at-buy-announces-price-target-of-4
HC Wainwright & Co. Assumes Adicet Bio at ...
07/23/2025 10:40:51

HC Wainwright & Co. analyst Robert Burns assumes Adicet Bio (NASDAQ:ACET) with a Buy rating and announces Price Target o...

why-block-shares-are-trading-higher-by-10-here-are-20-stocks-moving-premarket
Why Block Shares Are Trading Higher By 10%...
07/21/2025 10:04:54

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
05/09/2025 12:10:06

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/08/2025 21:05:48

adicet-bio-q1-eps-031-beats-034-estimate
Adicet Bio Q1 EPS $(0.31) Beats $(0.34) Es...
05/06/2025 20:38:44

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.34) by...

adicet-bio-to-give-oral-presentation-for-its-preclinical-adi-270-data-at-the-american-society-of-gene-and-cell-therapy-28th-annual-meeting
Adicet Bio To Give Oral Presentation For I...
04/28/2025 20:34:10

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
04/17/2025 21:05:38

guggenheim-reiterates-buy-on-adicet-bio-maintains-7-price-target
Guggenheim Reiterates Buy on Adicet Bio, M...
03/21/2025 14:04:18

Guggenheim analyst Yatin Suneja reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $7 price target.

citizens-capital-markets-reiterates-market-perform-on-adicet-bioto-market-perform
Citizens Capital Markets Reiterates Market...
03/07/2025 15:08:53

Citizens Capital Markets analyst Reni Benjamin reiterates Adicet Bio (NASDAQ:ACET) from Market Perform to Market Perform.

hc-wainwright--co-reiterates-neutral-on-adicet-bioto-neutral
HC Wainwright & Co. Reiterates Neutral on ...
03/07/2025 12:24:03

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) from Neutral to Neutral.

adicet-bio-reports-poster-presentations-highlighting-adi-270-data-at-sitc-2025-spring-scientific-meeting
Adicet Bio Reports Poster Presentations Hi...
03/03/2025 12:14:20

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION